JPH09505028A - 経皮的/経頬的にニコチン置換治療を提供する方法およびデバイス - Google Patents
経皮的/経頬的にニコチン置換治療を提供する方法およびデバイスInfo
- Publication number
- JPH09505028A JPH09505028A JP7504139A JP50413995A JPH09505028A JP H09505028 A JPH09505028 A JP H09505028A JP 7504139 A JP7504139 A JP 7504139A JP 50413995 A JP50413995 A JP 50413995A JP H09505028 A JPH09505028 A JP H09505028A
- Authority
- JP
- Japan
- Prior art keywords
- nicotine
- skin
- matrix
- composite
- matrix layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.所定の時間tにわたって人に対してニコチン置換治療を経皮的または経頬的 に提供するラミネート複合体であって、 (a)ニコチン不透過性バッキング層と、 (b)厚さ1を有し、かつ該治療を提供するのに十分な量のニコチンとポリマ ーとの混合物を含有するマトリックス層と、 の組み合わせを備えている複合体において、該ニコチンは該マトリックス層にお いて拡散係数Dを有しており、比 は、約0.5から約20の範囲であり、該複合体は、tの少なくとも50%の時間にわた って該ニコチンが皮膚または粘膜を通して投与される速度を制御し、かつtにわ たって該マトリックス層から投与されるニコチンの平均フラックスは50μg/cm2/ 時間よりも大きい、ラミネート複合体。 2.所定の時間tにわたって人に対してニコチン置換治療を経皮的または経頬的 に提供するラミネート複合体であって、 (a)ニコチン不透過性バッキング層と、 (b)厚さ1を有し、かつ該治療を提供するのに十分な量のニコチンとポリマ ーとの混合物を含有するマトリックス層と、 の組み合わせを備えている複合体において、該ニコチンは該マトリックス層にお いて拡散係数Dを有しており、比 は、約0.5から約20の範囲であり、該複合体は、tの少なくとも50%の時間にわた って該ニコチンが皮膚または粘膜を通して投与される速度を制御し、かつ該ニコ チンの該量の40%を超える量が、tの最初の50%以内の期間に該複合体から放出 される、ラミネート複合体。 3.所定の時間tにわたって人に対してニコチン置換治療を経皮的または経頬的 に提供するラミネート複合体であって、 (a)ニコチン不透過性バッキング層と、 (b)厚さ1を有し、かつ該治療を提供するのに十分な量のニコチンとポリマ ーとの混合物を含有するマトリックス層と、 の組み合わせを備えている複合体において、該ニコチンは該マトリックス層にお いて拡散係数Dを有しており、比 は、約0.5から約20の範囲であり、該複合体は、tの少なくとも50%の時間にわた って該ニコチンが皮膚または粘膜を通して投与される速度を制御し、かつ該時間 tの最後の1/3の時間にわたって該マトリックス層から投与されるニコチンの平均 フラックスの、該時間tの全期間にわたって該マトリックスから投与されるニコ チンの平均フラックスに対する比が約0.4未満である、ラミネート複合体。 4.前記ポリマーは感圧接着剤ポリマーであり、かつ前記複合体が人の皮膚に対 して拡散する関係になるように貼付される時に前記マトリックス層が該複合体の 基底面を規定する、請求項1、2または3に記載のラミネート複合体。 5.前記複合体が、前記マトリックス層の下地をなしかつ該複合体が人の皮膚に 対して拡散する関係になるように貼付される時に該複合体の基底面を規定するニ コチン透過性感圧接着剤層を備えている、請求項1、2または3に記載のラミネ ート複合体。 6.tが0.5時間以上24時間以下の範囲であり、 Dが1×10-9cm2/秒以上5×10-7cm2/秒以下の範囲であり、かつ 1が25ミクロン以上500ミクロン以下の範囲である、請求項1、2または3に記 載のラミネート複合体。 7.Dt/l2が0.75から5の範囲である、請求項1、2または3に記載のラミネー ト複合体。 8.前記ニコチンの前記量の約50%を超える量が、前記時間t以内に前記複合体 から放出される、請求項1、2または3に記載のラミネート複合体。 9.前記ポリマーが感圧シリコーン接着剤であり、かつ前記混合物がニコチンを 吸着する固体粒子状化合物を含んでいる、請求項1、2または3に記載のラミネ ート複合体。 10.tがおよそ24時間であり、1がおよそ260ミクロンであり、前記量がおよそ7 5mgであり、ニコチンを吸着する前記固体粒子状化合物がシリカゲルであり、か つ該シリカゲルが、乾燥接着剤シリカゲル混合物の組み合わせ重量に基づいてお よそ15重量パーセントをなす、請求項8に記載のラミネート複合体。 11.ニコチン置換治療を必要としている人に対して該治療を経皮的または経頬 的に提供する方法であって、請求項1、2、3、4、5、6、7、8、9または 10に記載のラミネート複合体を該人の皮膚または頬粘膜に対して拡散する関係 になるように貼付する工程を包含する、方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8997193A | 1993-07-09 | 1993-07-09 | |
US24752094A | 1994-05-23 | 1994-05-23 | |
US08/247,520 | 1994-05-23 | ||
US08/089,971 | 1994-05-23 | ||
PCT/US1994/007574 WO1995001766A1 (en) | 1993-07-09 | 1994-07-06 | Method and device for providing nicotine replacement therapy transdermally/transbuccally |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09505028A true JPH09505028A (ja) | 1997-05-20 |
Family
ID=26781125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7504139A Pending JPH09505028A (ja) | 1993-07-09 | 1994-07-06 | 経皮的/経頬的にニコチン置換治療を提供する方法およびデバイス |
Country Status (7)
Country | Link |
---|---|
US (1) | US5603947A (ja) |
EP (1) | EP0708627B1 (ja) |
JP (1) | JPH09505028A (ja) |
AU (1) | AU7323794A (ja) |
CA (1) | CA2166869A1 (ja) |
DE (1) | DE69422925T2 (ja) |
WO (1) | WO1995001766A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005314262A (ja) * | 2004-04-28 | 2005-11-10 | Sekisui Plastics Co Ltd | 外用貼付剤およびその製造方法、並びにその使用方法 |
JP2006525317A (ja) * | 2003-04-29 | 2006-11-09 | ニューリム ファーマシューティカルズ(1991)リミテッド | 認知および記憶を改善するための組成物 |
JP2015508799A (ja) * | 2012-03-02 | 2015-03-23 | ピエール、ファーブル、メディカマン | 多孔質微粒子を含む経皮デバイス |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5719197A (en) * | 1988-03-04 | 1998-02-17 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
AU4761196A (en) * | 1995-01-19 | 1996-08-07 | Cygnus, Inc. | Polymer adhesive formulation containing sorbent particles |
US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
EP0833671A2 (en) * | 1995-06-07 | 1998-04-08 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
US5800832A (en) * | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
US5843472A (en) * | 1997-02-28 | 1998-12-01 | Cygnus, Inc. | Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use |
US7150881B2 (en) | 1997-06-26 | 2006-12-19 | Mylan Technologies, Inc. | Adhesive mixture for transdermal delivery of highly plasticizing drugs |
KR100885235B1 (ko) † | 1998-12-07 | 2009-02-24 | 엘란 파마 인터내셔널 리미티드 | 휘발성 액상 약물 전달을 위한 경피성 패취 |
DE69941629D1 (de) | 1998-12-18 | 2009-12-17 | Alza Corp | Durchsichtige transdermale nicotinabgabevorrichtungen |
US6974588B1 (en) * | 1999-12-07 | 2005-12-13 | Elan Pharma International Limited | Transdermal patch for delivering volatile liquid drugs |
US20070225379A1 (en) * | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
US7214381B2 (en) * | 2000-08-03 | 2007-05-08 | Antares Pharma Ipl Ag | Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
US7198801B2 (en) * | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
KR100377336B1 (ko) * | 2000-11-17 | 2003-03-26 | 학교법인 카톨릭학원 | 엔-포밀-리신의 제조방법 및 이를 이용한 글리케이션화단백질의 분석방법 |
DE10110391A1 (de) | 2001-03-03 | 2002-09-26 | Lohmann Therapie Syst Lts | Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff |
US20040086551A1 (en) * | 2002-10-30 | 2004-05-06 | Miller Kenneth J. | Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
US7306812B2 (en) | 2003-05-09 | 2007-12-11 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
WO2005009386A2 (en) * | 2003-07-24 | 2005-02-03 | Smithkline Beecham Corporation | Orally dissolving films |
US7387788B1 (en) | 2003-10-10 | 2008-06-17 | Antares Pharma Ipl Ag | Pharmaceutical compositions of nicotine and methods of use thereof |
MXPA06003316A (es) | 2003-10-10 | 2006-06-08 | Antares Pharma Ipl Ag | Formulacion farmaceutica transdermica para minimizar los residuos en la piel. |
US7425340B2 (en) * | 2004-05-07 | 2008-09-16 | Antares Pharma Ipl Ag | Permeation enhancing compositions for anticholinergic agents |
WO2007124250A2 (en) * | 2006-04-21 | 2007-11-01 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
US20060264455A1 (en) * | 2005-05-23 | 2006-11-23 | Schachter Steven C | Use of huperzine for disorders |
WO2006125642A1 (en) | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
KR100699582B1 (ko) | 2005-07-11 | 2007-03-23 | 삼성전기주식회사 | 출력 버퍼회로 |
US7888422B2 (en) | 2005-11-09 | 2011-02-15 | Mylan Technologies Inc. | Long-wearing removable pressure sensitive adhesive |
SI2054031T1 (sl) | 2006-07-21 | 2016-09-30 | Biodelivery Sciences International, Inc. | Transmukozne naprave za administracijo z izboljšanim vnosom |
WO2008067991A2 (en) * | 2006-12-08 | 2008-06-12 | Antares Pharma Ipl Ag | Skin-friendly drug complexes for transdermal administration |
WO2008080064A1 (en) | 2006-12-21 | 2008-07-03 | Trustees Of Tufts College | Synthetic lipophilic inositol glycans for treatment of cancer and glucose-metabolism disorders |
US9017301B2 (en) * | 2007-09-04 | 2015-04-28 | Mylan Technologies, Inc. | Transdermal drug delivery systems comprising a coated release liner |
EP2328584A4 (en) * | 2008-09-04 | 2012-01-18 | Harvard College | TREATMENT OF NEUROLOGICAL DISORDERS USING HUPERZINE |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
WO2011137491A1 (en) * | 2010-05-06 | 2011-11-10 | University Of South Australia | Novel drug delivery system |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US8499764B2 (en) | 2010-05-26 | 2013-08-06 | The Invention Science Fund I, Llc | Portable apparatus for establishing an isolation field |
EA201991223A1 (ru) | 2011-08-18 | 2019-10-31 | Не вызывающие зависимость мукоадгезивные устройства для доставки бупренорфина | |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
BR112020025604A2 (pt) | 2018-06-15 | 2021-03-23 | R.J. Reynolds Tobacco Company | purificação de nicotina |
CN111084401B (zh) * | 2018-10-24 | 2022-05-03 | 贵州中烟工业有限责任公司 | 一种烟叶混配方法 |
DE102020112143B4 (de) | 2020-05-05 | 2022-03-17 | Lts Lohmann Therapie-Systeme Ag | Nicotin - Corona |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4496853A (en) * | 1982-11-08 | 1985-01-29 | General Instrument Corporation | Static load for high voltage driver |
EP0177329B1 (en) * | 1984-10-05 | 1992-09-30 | Hercon Laboratories Corporation | Device for transdermal drug administration |
DE3438284A1 (de) * | 1984-10-16 | 1985-03-07 | Hans-Harald von 2400 Lübeck Tilly | Nikotinhaltiges depotpflaster |
US5016652A (en) * | 1985-04-25 | 1991-05-21 | The Regents Of The University Of California | Method and apparatus for aiding in the reduction of incidence of tobacco smoking |
IL86170A (en) * | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
US4839174A (en) * | 1987-10-05 | 1989-06-13 | Pharmetrix Corporation | Novel transdermal nicotine patch |
US4943435A (en) * | 1987-10-05 | 1990-07-24 | Pharmetrix Corporation | Prolonged activity nicotine patch |
US5064654A (en) * | 1989-01-11 | 1991-11-12 | Ciba-Geigy Corporation | Mixed solvent mutually enhanced transdermal therapeutic system |
JP2677371B2 (ja) * | 1988-01-30 | 1997-11-17 | 帝國製薬株式会社 | 含水性喫煙代用貼付剤 |
US4877618A (en) * | 1988-03-18 | 1989-10-31 | Reed Jr Fred D | Transdermal drug delivery device |
US5004610A (en) * | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
US5091186A (en) * | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
CA2065403C (en) * | 1989-09-14 | 1996-06-18 | Gary W. Cleary | Transdermal delivery device having delayed onset |
ATE148633T1 (de) * | 1990-03-28 | 1997-02-15 | Noven Pharma | Verfahren und vorrichtung zur freisetzung von arzneimittel an die haut |
JPH07116032B2 (ja) * | 1990-04-06 | 1995-12-13 | 積水化学工業株式会社 | ニトログリセリン貼付剤 |
US5508038A (en) * | 1990-04-16 | 1996-04-16 | Alza Corporation | Polyisobutylene adhesives for transdermal devices |
CA2062828C (en) * | 1990-04-24 | 1996-04-16 | Osafumi Hidaka | Pharmaceutical plasters |
JPH0477419A (ja) * | 1990-07-17 | 1992-03-11 | Teisan Seiyaku Kk | 貼付用の製剤 |
GB9016056D0 (en) * | 1990-07-21 | 1990-09-05 | Chatfield Pharmaceuticals Limi | Transdermal medicine delivery devices |
IT1243745B (it) * | 1990-10-17 | 1994-06-21 | Vectorpharma Int | Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione. |
TW221970B (ja) * | 1991-06-26 | 1994-04-01 | Tbs Lab Inc | |
US5232702A (en) * | 1991-07-22 | 1993-08-03 | Dow Corning Corporation | Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices |
-
1994
- 1994-07-06 CA CA002166869A patent/CA2166869A1/en not_active Abandoned
- 1994-07-06 DE DE69422925T patent/DE69422925T2/de not_active Expired - Lifetime
- 1994-07-06 JP JP7504139A patent/JPH09505028A/ja active Pending
- 1994-07-06 AU AU73237/94A patent/AU7323794A/en not_active Abandoned
- 1994-07-06 EP EP94923343A patent/EP0708627B1/en not_active Expired - Lifetime
- 1994-07-06 WO PCT/US1994/007574 patent/WO1995001766A1/en active IP Right Grant
- 1994-07-21 US US08/278,277 patent/US5603947A/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006525317A (ja) * | 2003-04-29 | 2006-11-09 | ニューリム ファーマシューティカルズ(1991)リミテッド | 認知および記憶を改善するための組成物 |
JP2012116859A (ja) * | 2003-04-29 | 2012-06-21 | Neurim Pharmaceuticals (1991) Ltd | 認知および記憶を改善するための組成物 |
JP2005314262A (ja) * | 2004-04-28 | 2005-11-10 | Sekisui Plastics Co Ltd | 外用貼付剤およびその製造方法、並びにその使用方法 |
JP4557596B2 (ja) * | 2004-04-28 | 2010-10-06 | 積水化成品工業株式会社 | 外用貼付剤およびその製造方法、並びにその使用方法 |
JP2015508799A (ja) * | 2012-03-02 | 2015-03-23 | ピエール、ファーブル、メディカマン | 多孔質微粒子を含む経皮デバイス |
Also Published As
Publication number | Publication date |
---|---|
EP0708627B1 (en) | 2000-02-02 |
US5603947A (en) | 1997-02-18 |
DE69422925T2 (de) | 2000-08-17 |
WO1995001766A1 (en) | 1995-01-19 |
AU7323794A (en) | 1995-02-06 |
CA2166869A1 (en) | 1995-01-19 |
DE69422925D1 (de) | 2000-03-09 |
EP0708627A1 (en) | 1996-05-01 |
EP0708627A4 (en) | 1997-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09505028A (ja) | 経皮的/経頬的にニコチン置換治療を提供する方法およびデバイス | |
KR100885235B1 (ko) | 휘발성 액상 약물 전달을 위한 경피성 패취 | |
JP2701951B2 (ja) | プリントされた皮膚透過性薬剤投与具 | |
US6974588B1 (en) | Transdermal patch for delivering volatile liquid drugs | |
KR950001968B1 (ko) | 펜타닐의 경피투여용 적층 혼성체 | |
JP4511691B2 (ja) | 経皮的投与のためのマトリックスパッチ | |
US4690683A (en) | Transdermal varapamil delivery device | |
JP4628673B2 (ja) | 活性成分フェンタニルを含む経皮治療システム(tts) | |
RU2272625C2 (ru) | Чрескожная терапевтическая система для лечения болезни паркинсона, индуцирующая высокие уровни ротиготина в плазме | |
CA2563110A1 (en) | Rivastigmine comprised in a transdermal therapeutic system for use in the treatment of dementia or alzheimer disease | |
US20080044461A1 (en) | Transdermal methods and systems for treating Alzheimer's disease | |
JPH07503232A (ja) | メラトニンの制御経皮投与 | |
JPH08502952A (ja) | オキシブチニンの経皮投与 | |
JPH04507256A (ja) | 二相性経皮薬物供給デバイス | |
FR2581314A1 (fr) | Dispositif medical pour l'administration transdermique de medicaments fortement ionises insolubles dans les corps gras | |
JP2016502989A5 (ja) | ||
WO2001026705A2 (en) | A dual adhesive transdermal drug delivery system | |
JPS63233916A (ja) | 弾力性経皮薬剤供給デバイス,およびアルカンジオールの脂肪酸エステル/エーテルを経皮吸収促進剤とする組成物およびデバイス | |
WO2000033812A9 (en) | Transdermal patch for delivering volatile liquid drugs | |
JP2002531488A5 (ja) | ||
JPH11506462A (ja) | ロピニロールを含有してなる経皮製剤 | |
WO2004060268A2 (en) | A method and article to control cellulite | |
JPH02258717A (ja) | 活性物質の作用を遅延及び制御する形の皮膚経由又は粘膜経由投与のための治療薬 | |
EP1449527A2 (en) | Transdermal patch for administering a volatile liquid drug | |
KR100579721B1 (ko) | 툴로부테롤을 함유하는 경피투여용 패취제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040511 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040622 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060314 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060509 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20070117 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20070117 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070724 |